APOA1 and neoplasm: ApoAI and ApoAI mimetic peptides have been shown to inhibit tumor development in a mouse model of ovarian cancer, suggesting that ApoAI may not only have potential as a biomarker, but may also have therapeutic utility in this disease [35].